DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from Kythera Labs
Many of these therapies also support once-weekly or even once-monthly dosing, enhancing adherence in populations where polypharmacy or injection fatigue is a concern
Minimum Documentation Checklist Confirmed Type 2 diabetes diagnosis: Active problem list entry or explicit mention in the encounter note Neuropathy established by provider: Direct statement linking neuropathy to diabetes (not just patient-reported symptoms) No subtype specified: No mention of mononeuropathy, polyneuropathy, autonomic neuropathy, or amyotrophy anywhere in the encounter documentation Causal attribution documented: Due to diabetes, diabetic neuropathy, or equivalent clinical language present Maintaining structured patient records that capture complication types at each encounter reduces the documentation gaps that force coders to default to E11.40
However, space it away from calcium and high-fiber supplements by at least 2 hours to optimize absorption
The dosage often varies based on the specific GLP-1 agonist being used
The penumbra is where intervention matters most, because neurons in this zone can be saved if the right signals arrive in time
